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Abstract: We report herein the asymmetric coupling of flow-
generated unstabilized diazo compounds and propargylated
amine derivatives, using a new pyridinebis(imidazoline)
ligand, a copper catalyst and base. The reaction proceeds
rapidly, generating chiral allenes in 10–20 minutes with high
enantioselectivity (89–98% de/ee), moderate yields and a wide
functional group tolerance.
Allenes continue to hold a general interest due to their
cumulated, orthogonal p bonds. Since their initial discovery,
they have been found in natural products and incorporated
into various functional materials.[1,2] Perhaps most impor-
tantly, however, is their utilization in a wide range of chemical
transformations, especially cycloadditions[3] and cyclization
reactions.[4]
The asymmetric synthesis of allenes remains an under-
developed area, with most precedent literature proceeding
via SN2’ type reactions with enantiopure propargyl deriva-
tives.[5] Enantioselective coupling reactions of two simpler
fragments using catalytic quantities of chiral ligand are even
scarcer, due to the difficulty in controlling the stereochemistry
of a three-carbon axially chiral skeleton. Existing reports
utilizing chiral ligands include the coupling of aldehydes and
terminal alkynols in the presence of (R,R)-N-PINAP[6] and
the coupling of stabilized a-diazoesters with terminal alkynes
using chiral guanidinium salts (Scheme 1).[7] Very recently, an
asymmetric process was described by Wang et al. to generate
trisubstituted allenes using unstabilized ketone-derived diazo
compounds (72–98% ee).[8]
We reported earlier the room-temperature racemic cou-
pling of unstabilized flow-generated diazo compounds with
terminal alkynes and found the process to be extremely
general, tolerating a large range of functional groups as
a consequence of the mild conditions utilized for the diazo
partner generation.[9] It would therefore be highly desirable to
assess whether these same benefits[10, 11] would allow an
enantioselective variant of the process, in the presence of an
appropriate chiral ligand. We report herein a method to
access chiral disubstituted allenes via flow-generated alde-
hyde-derived diazo compounds and terminal alkynes, using
a new pyridinebis(imidazoline) ligand designed for this
purpose.
With the knowledge that hydrazone 1a is able to generate
the corresponding diazo compound 2a in the presence of
activated MnO2 under flow conditions, an initial ligand
screen was developed for the coupling with alkyne 3a
(Table 1). We found that tridentate ligands were suitable
for inducing enantioselectivity, whereas mono- and bi-
dentate ligands did not result in any selectivity (see the
Supporting Information (SI) for further details). These results
suggest that our tridentate ligand-mediated process for
disubstituted allene synthesis is complementary to the
bidentate ligand-mediated trisubstituted allene process de-
scribed by Wang et al.[8] Interestingly, the commercially
available (S)-iPr-PyBOX (L1) provided coupling products
4a and 4a’, in a 38:62 ratio with 68% ee (entry 1). Attempts at
Scheme 1. Asymmetric coupling reactions for allene synthesis using
catalytic chiral ligand.
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changing the structure of the PyBOX ligand offered some
improvement in enantioselectivity (84% ee, entry 3), though
frustratingly, the desired allene remained a minor product of
the reaction.
Fortunately, switching the flanking oxazoline units to
imidazolines (PyBIMs) proved fruitful, allowing an improve-
ment in the enantioselectivity (96% ee, entry 4). In particular,
para-substituted electron-withdrawing groups on the N-aryl
substituent proved essential to providing allene 4a as the
major product, with the 4-SF5 group providing the best result
(entry 9). Further increases in the electron deficiency (4-nitro
and 4-triflyl, entries 10 and 11) of the aromatic ring provided
moderate enantioselectivities, presumably due to poorer
binding to the copper center. We believe that the ambidentate
oxazoline units of the more commonly used PyBOX ligands
are the origin of this differing efficiency in enantioselectivity,
as coordination to the oxygen atom could lead to poorer
enantioselection (see SI for a detailed discussion). In contrast,
PyBIM ligands were superior as they offer only a single
binding site on the imidazoline units. Furthermore, modu-
lation of electronic effects was critical to achieve correct
coupling selectivity. To the best of our knowledge, this is the
first rationalization of the performance of PyBOX versus
PyBIM ligands,[12] which could be important for future
development of new catalytic asymmetric reactions.
With the new ligand in hand, we then tested a variety of
propargylated amine derivatives and flow-generated diazo
compounds for the asymmetric allenylation reaction
(Table 2). Overall although yields in general are moderate
(30–57%), the enantioselectivity of the reaction is excellent
(89–98% de/ee) and proceeds rapidly under mild conditions.
The remaining mass balance was mainly due to the alkyne
cross-coupled product, which could generally be removed by
careful column chromatography. A myriad of sensitive func-
tional groups were found to be compatible with the reaction
conditions, including ketones (4c), aldehydes (4d), epoxides
(4e), unprotected alcohols (4 i), esters (4 l, 4u) and terminal/
internal olefins (4s, 4t and 4v), all with excellent enantiose-
lectivities. Notably, several heterocyclic examples including
thiophenes (4 f), furans (4j), indoles (4ac) and pyrroles (4ad)
were also tolerated despite their potential to interfere with
the catalytic cycle, all with good enantioselectivity. Variation
in the electronic properties of the diazo compound had
a small effect on the yield and enantioselectivity, with more
electron-withdrawing substituents such as 4-fluoro (4o) and
3-cyano (4q) leading to slightly lower ee values (91% ee and
89% ee, respectively, compared to 94–96% ee for 4m, 4n, 4p
and 4r). It was also easy to scale up the asymmetric
allenylation to 5 mmol of propargylamide for allene 4w in
our flow system without the need to store excessive quantities
of diazo compound, which provided 0.89 g of chiral material
in similar yield and ee to the smaller scale run.
To further probe the functional group tolerance of this
procedure, we were able to conduct the late-stage asymmetric
allenylation of various propargylated amine derivatives of
seven drug molecules/natural products (4x–4ad), including
(S)-ibuprofen, aspirin, penicillin G, topiramate, pregabalin,
indomethacin and atorvastatin, again all proceeding with high
de/ee values. Surprisingly, the presence of the thioether
functionality on penicillin G was not detrimental to the
stereoselectivity.
We were able to demonstrate the utility of the chiral
allenes generated in a medicinal chemistry context by
conducting the silver-mediated cyclization[13] of allene 4a to
its corresponding 3-pyrroline 5 (Scheme 2), with good chir-
ality transfer and excellent yield (97% ee to 95% ee). The
process can therefore overall be regarded as a formal
enantioselective sp2–sp3 coupling, with a functional handle
(internal olefin) for potential further derivatization.
We anticipate that the reaction mechanism proceeds as
depicted below (Scheme 3). In the presence of base and the
copper catalyst, the initially generated ligand–copper acety-
Table 1: Ligand screening for asymmetric allene synthesis.[a]
[a] Using 0.2 mmol of alkyne 3a, 0.02 mmol of CuI, 0.03 mmol of ligand and 0.4 mmol of Et3N at RT in 2 mL 1,4-dioxane, with 0.4 mmol of hydrazone
1a (with DIPEA as buffer) flowed through activated MnO2 then a back pressure regulator (BPR). All reactions proceeded in >95% conversion.
[b] Allene/alkyne ratio determined by 1H NMR analysis of the crude reaction mixture. [c] ee determined by chiral HPLC.
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lide complex 7 undergoes an enantioselective concerted Cu@
C bond insertion with the diazo compound 2. The approach of
this species is controlled by the bulky tBu arms of the PyBIM
ligand, with the hydrogen substituent of the diazo compound
on the same side as the ligand tBu groups. Selective 1,3-
protonation (most likely via the N@H group from the amide/
sulfonyl group) of the transient copper species 8 from the
front face of the catalyst then generates the desired allene 4
and regenerating the ligand–copper complex 6. It appears that
the copper species 8 is fairly labile and can dissociate leading
to the anionic species 9, which subsequently protonates to
give the undesired alkyne cross-coupled product 4’.[14]
In summary, we have reported a new flow-enabled
catalytic asymmetric coupling reaction of aldehyde-derived
unstabilized diazo compounds with propargylamine deriva-
tives, proceeding rapidly in moderate yields and high
enantioselectivities. Given the underdeveloped methods for
enantioselective allene synthesis, our results represent an
important achievement in this field, particularly due to the
high level of functional group tolerance and potential for late-
stage functionalization. Further investigations into generaliz-
ing the scope and the development of new bifunctional
ligands are currently ongoing in our laboratories.
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